Valuation: B.R.A.I.N. Biotechnology Research and Information Network AG

Market Cap 64.89M 75.13M 61.05M 55.49M 104M 7.2B 106M 716M 281M 3.6B 282M 276M 11.99B P/E 2026 *
-7.58x
P/E 2027 * -12x
Enterprise Value 87.29M 101M 82.13M 74.65M 140M 9.68B 142M 963M 378M 4.84B 379M 371M 16.13B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.47x
Free-Float
41.64%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: B.R.A.I.N. Biotechnology Research and Information Network AG

Manager TitleAgeSince
Chief Executive Officer 62 31/01/2020
Director of Finance/CFO 56 30/09/2022
Chief Tech/Sci/R&D Officer 40 31/12/2022
Director TitleAgeSince
Director/Board Member 54 08/03/2017
Chairman 65 07/03/2023
Director/Board Member 61 13/10/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 72.88M
+0.57%+0.14%-45.33%-78.37% 204M
-1.88%-9.77%+185.45%+513.28% 139M
-0.86%+1.94%+14.88%-47.36% 88.31M
Average -0.38%-1.89%+51.67%+129.18% 143.91M
Weighted average by Cap. -0.27%-2.22%+41.45%+118.89%

Financials

2026 *2027 *
Net sales 53.57M 62.02M 50.4M 45.81M 86.15M 5.94B 87.42M 591M 232M 2.97B 233M 228M 9.9B 62.66M 72.54M 58.95M 53.58M 101M 6.95B 102M 692M 271M 3.48B 272M 266M 11.58B
Net income -8.24M -9.54M -7.76M -7.05M -13.26M -914M -13.45M -90.97M -35.65M -457M -35.83M -35.05M -1.52B -5.23M -6.06M -4.92M -4.47M -8.41M -580M -8.53M -57.72M -22.62M -290M -22.73M -22.24M -967M
Net Debt 22.41M 25.94M 21.08M 19.16M 36.04M 2.49B 36.57M 247M 96.92M 1.24B 97.4M 95.29M 4.14B 27.4M 31.72M 25.78M 23.43M 44.07M 3.04B 44.71M 302M 119M 1.52B 119M 117M 5.06B
Logo B.R.A.I.N. Biotechnology Research and Information Network AG
BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Employees
280
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-